Metabolic Effects of a Thermogenic Ready-to-drink Beverage

Status Completed

Clinical Trial Summary

This study is a randomized, double-blind, placebo-controlled crossover trial examining the metabolic effects of a novel ready-to-drink (RTD) beverage. Healthy adult males and females will be recruited for participation. Each participant will complete two conditions in random order: 1) RTD thermogenic beverage ; and 2) placebo (consisting of the flavoring of the thermogenic beverage without the active ingredients). In each condition, metabolism (resting metabolic rate), hemodynamic (heart rate and blood pressure), and subjective (ratings of energy, focus, concentration, alertness, and mood) assessments will be completed at baseline, 30 minutes after beverage consumption, and 30 minutes after the second round of assessments.

Clinical Trial Description

The primary purpose of this study is to report the metabolic effects of a new ready-to-drink (RTD) version of EHP Labs OxyShred Thermogenic Fat Burner. Additionally, the effect of this product on hemodynamic variables and subjective ratings of energy, focus, concentration, alertness, and mood will be reported. OxyShred Thermogenic Fat Burner (EHP Labs) is a popular dietary supplement for those seeking to increase energy and reduce body fat. While this product is commercially available as a powdered dietary supplement, a new RTD formulation is currently being developed. While the RTD formula will be similar to the current version of the product, research specifically conducted with the RTD version is needed to definitively support product claims and demonstrate the potential effects of this novel product. Additionally, there is a need to better understand the effects of caffeine-containing, thermogenic products among the variety of groups who may consume these products (e.g., males vs. females, inactive vs. active, etc.). This study is a randomized, double-blind, placebo-controlled crossover trial examining the metabolic effects of a novel ready-to-drink (RTD) beverage. Healthy adult males and females will be recruited for participation. Each participant will complete two conditions in random order: 1) RTD thermogenic beverage ; and 2) placebo (consisting of the flavoring of the thermogenic beverage without the active ingredients). In each condition, metabolism (resting metabolic rate), hemodynamic (heart rate and blood pressure), and subjective (ratings of energy, focus, concentration, alertness, and mood) assessments will be completed at baseline, 30 minutes after beverage consumption, and 30 minutes after the second round of assessments. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05194475
Study type	Interventional
Source	Texas Tech University
Contact
Status	Completed
Phase	N/A
Start date	January 18, 2022
Completion date	May 6, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00070577` - Influence of Age and Sex on Alcohol Metabolism and Acute Responses	N/A
Active, not recruiting	`NCT05488574` - Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss	N/A
Recruiting	`NCT05582824` - Lactate Metabolism in the Hypoperfused Critically Ill
Recruiting	`NCT05443347` - Activity, Adiposity, and Appetite in Adolescents 2 Intervention	N/A
Completed	`NCT05020808` - The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise	N/A
Recruiting	`NCT06082726` - The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers	N/A
Completed	`NCT04144426` - Meal Schedule Effects on Circadian Energy Balance in Adults	N/A
Completed	`NCT03424395` - Personalized Dietary Program and Markers of Wellness	N/A
Completed	`NCT02441296` - Carbohydrate and Metabolism: a Pilot Study	N/A
Completed	`NCT00176085` - Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH	Phase 1
Completed	`NCT00245986` - Effect of Genetics on Metabolism of Efavirenz	Phase 4
Completed	`NCT04025346` - To Evaluate the Efficacy of Capsimax on Metabolic Rate	N/A
Completed	`NCT04078646` - Influence of Proteins on the Bioavailability of Carotenoids	N/A
Active, not recruiting	`NCT06033898` - Inactivity Duration on Lipid Metabolism	N/A
Active, not recruiting	`NCT06250270` - Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning	Early Phase 1
Completed	`NCT06285578` - Effects of Probiotic and HIIT in Obese Women	N/A
Completed	`NCT04255368` - Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response	N/A
Recruiting	`NCT06360796` - Study of Pharmacokinetics and Metabolism on [(14)C]ADC189	Phase 1
Recruiting	`NCT02005003` - Cognitive and Metabolic Effects of a Probiotic Supplement	N/A
Completed	`NCT03146728` - Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.